The impact of the menstrual cycle on exacerbations of atopic dermatitis: a systematic review.

IF 3.7 4区医学 Q1 DERMATOLOGY

Clinical and Experimental Dermatology Pub Date : 2025-04-02 DOI:10.1093/ced/llaf153

Niamh Theresa McSwiney, Eliza Hutchison, Rosa Moran, Alexandra Phillips, Daya Sumra, Hannah Wainman

{"title":"The impact of the menstrual cycle on exacerbations of atopic dermatitis: a systematic review.","authors":"Niamh Theresa McSwiney, Eliza Hutchison, Rosa Moran, Alexandra Phillips, Daya Sumra, Hannah Wainman","doi":"10.1093/ced/llaf153","DOIUrl":null,"url":null,"abstract":"Background: Atopic dermatitis (AD) is a chronic pruritic inflammatory skin condition. Patients often report experiencing cutaneous deterioration associated with certain points of their menstrual cycle. Despite this, the literature surrounding this topic remains sparse. This review aims to summarise and compare recent publications surrounding the association between the different stages of the menstrual cycle and exacerbations of atopic dermatitis.Methods: A literature review was conducted as per PRISMA guidelines using Ovid Medline, Embase, Cochrane Library, PubMed and Web of Science. Search terms and variations on these terms included: menstruation, eczema and atopic dermatitis. A minimum of 2 authors independently screened each abstract and reviewed the full-texts for inclusion.Results: A total of 16 studies were included. All articles consistently acknowledged premenstrual deterioration in control of atopic dermatitis, typically occurring in the week prior to menstruation.Conclusion: Our results highlight that the premenstrual exacerbation of AD is a well-recognised phenomenon, typically occurring in the week prior to menstruation. Existing studies are of a low quality and we identified minimal evidence on treatment strategies for premenstrual AD exacerbations. Further large-scale studies are needed to explore treatment options for these patients, such as hormonal therapies.","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ced/llaf153","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Atopic dermatitis (AD) is a chronic pruritic inflammatory skin condition. Patients often report experiencing cutaneous deterioration associated with certain points of their menstrual cycle. Despite this, the literature surrounding this topic remains sparse. This review aims to summarise and compare recent publications surrounding the association between the different stages of the menstrual cycle and exacerbations of atopic dermatitis.

Methods: A literature review was conducted as per PRISMA guidelines using Ovid Medline, Embase, Cochrane Library, PubMed and Web of Science. Search terms and variations on these terms included: menstruation, eczema and atopic dermatitis. A minimum of 2 authors independently screened each abstract and reviewed the full-texts for inclusion.

Results: A total of 16 studies were included. All articles consistently acknowledged premenstrual deterioration in control of atopic dermatitis, typically occurring in the week prior to menstruation.

Conclusion: Our results highlight that the premenstrual exacerbation of AD is a well-recognised phenomenon, typically occurring in the week prior to menstruation. Existing studies are of a low quality and we identified minimal evidence on treatment strategies for premenstrual AD exacerbations. Further large-scale studies are needed to explore treatment options for these patients, such as hormonal therapies.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

2.40%

发文量

389

审稿时长

3-8 weeks

期刊介绍： Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.